If you wish to logout, click here. You may be prompted to
sign in again in order to view our content.

Login or register to view this section.

Login or register to view this section.

Your account gives you full control over what you receive from us. You must have an active account and be logged in to access certain parts of the website.

Within your account, you will also have the option to receive information from us, such as our magazine and our email newsletters. You may opt in or out of any of these options at any time, and may deactivate your account by contacting us.

We also ask a few questions about you and the information in which you are interested - these are optional, but help us ensure we can deliver you a more personalised experience on our site.

You're trying to access an editorial feature that is only available to logged in,
registered users of Scientific Computing World. Registering is completely free, so why not sign up with us?

By registering, as well as being able to browse all content on the site without further
interruption, you'll also have the option to receive our magazine (multiple times a year) and our
email newsletters.

With significant new technology enhancements in the areas of security, administration and scientific services, Accelrys is extending the enterprise capabilities of the platform, providing organisations with powerful new tools for streamlining the lab-to-commercialisation value chain within and outside of the firewall and driving innovation in new product development.

'Our customers across industries have more scientific data to help them innovate than ever before, yet their ability to efficiently transform that data into knowledge is limited by tools and processes that fail to take an integrated, holistic approach to new product development,' said Accelrys president and chief executive officer Max Carnecchia.

'A year ago, Accelrys issued an industry-wide challenge to close the productivity gap hampering innovation. We remain committed to that effort and we believe that Accelrys Enterprise Platform 9.0 marks a significant advance in helping our customers accelerate innovation.'

Latest issue

In January 2020 the American Diabetes Association released a new set of clinical standards that, for the first time, included the use of an FDA-approved autonomous artificial intelligence (AI) platform for detecting diabetic retinopathy in people with diabetes.

At the end of February physIQ and the US Department of Veteran’s Affairs published data from a clinical trial demonstrating the use of physIQ’s machine-learning algorithm to predict when an individual patient with previously diagnosed heart failure will likely require a readmission to hospital.

New processors and GPU technology continue to demand more power than the previous generations, combining this with increasingly dense architectures requires cooling solutions such as liquid or immersion cooling.